🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection

Recruitingn/aAges 5 Years - anyAllJose Ivan Rodriguez de Molina Serrano
NCT07007585 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This 3-year prospective observational study aims to identify clinical and laboratory risk factors associated with hospitalization in patients with confirmed dengue virus infection. It also seeks to analyze real-world transfusion practices and their outcomes. The study will be conducted in a second-level hospital in northern Mexico and will follow patients from emergency department entry to clinical resolution or hospital discharge.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged ≥5 years * Laboratory-confirmed dengue infection (NS1, IgM, or PCR) * First contact at emergency or outpatient services * Informed consent signed by the patient or legal guardian Exclusion Criteria: * Co-infection with other arboviruses or COVID-19 * Pre-existing hematologic or oncologic disease * Refusal to sign informed consent
💊

What it tests

  • Not listed
📍

Where

1 site
Clinica Mexico
Piedras Negras, Mexico
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy